First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...
A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...
According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...
An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...
The protein, reverse transcriptase, has become an essential tool for making DNA copies of RNA.
Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...
Yan has chosen to sever all contact with her family, saying she fears even speaking to them could endanger her. The husband ...
In September, David Baltimore — the scientist who discovered reverse transcriptase, a breakthrough often described as one of ...
Avatar: Fire & Ash stars Sam Worthington and Stephen Lang talked to us about how their characters have changed throughout the ...
YouTube on MSN
COVID Variant Recombination: Threat or Achilles Heel?
Scientists may have found a recombinant variant of COVID-19 in the wild, and its mixed dna could be essential to the coronavirus life cycle. Hosted by: Hank Green SciShow has a spinoff podcast! It's ...
Discover the essential role of TGF-Beta 1 in cellular regulation, its signaling pathway, and how TGF-β1 antibodies are used ...
The vaccine developers market shows significant opportunities through increased demand, collaborative partnerships, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback